Artisan Partners
PTLA

Artisan Partners’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Artisan Partners’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-222,833
Closed -$11.5M – 388
2015
Q4 		$11.5M Buy
222,833
+21,860
+11% +$1.06M 0.02% 260
2015
Q3 		$8.56M Buy
200,973
+19,562
+11% +$944K 0.02% 298
2015
Q2 		$8.26M Buy
181,411
+64,771
+56% +$2.61M 0.02% 314
2015
Q1 		$4.43M Buy
+116,640
New +$4.01M 0.01% 351

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Artisan Partners's PTLA Position: Q1 2016 in Review

Artisan Partners sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2016, closing a stake of 222,833 shares — an estimated $11.5M sold.

Artisan Partners first reported a position in PTLA in Q1 2015 and held it in 4 quarters. The position peaked at $11.5M in Q4 2015. 167 funds tracked by Wall St. Rank hold PTLA as of Q1 2016.

  • Artisan Partners reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Artisan Partners sold 222,833 Portola Pharmaceuticals, Inc. shares in Q1 2016, an estimated $11.5M.
  • Artisan Partners first reported a position in Portola Pharmaceuticals, Inc. in Q1 2015 and held it in 4 quarters.
  • Artisan Partners's Portola Pharmaceuticals, Inc. position peaked at $11.5M in Q4 2015.
  • 167 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2016.

Based on Artisan Partners's 13F filing for Q1 2016, filed 12 May 2016.